Financial Highlights
In billion Rupiah
(unless otherwise stated)
2008
Actual
2009
Actual
2010
Actual
2011
Actual
2012
Actual
Net Sales
11,840
9,040
9,484
12,605
13,845
Gross Proft
4,129
3,225
3,750
4,601
4,164
Gain/(Loss) Arising from Changes in Fair Values of
Biological Assets
(947)
623
309
425
56
Operating Income
1,864
3,264
3,026
3,777
2,708
Net Proft
1,067
2,053
1,906
2,641
1,819
Net Proft to Equity Holders
795
1,527
1,402
1,490
1,049
EPS (in Rupiah)
550
1,061
974
1,031
730
Current Assets
4,294
3,837
6,118
9,437
8,318
Fixed Assets
12,529
15,183
17,244
18,860
21,047
Other Assets
4,040
4,628
4,827
4,910
5,447
Total Assets
20,863
23,648
28,189
33,207
34,811
Current Liabilities
3,826
2,925
4,125
4,792
4,609
Non-Current Liabilities
6,061
7,743
8,363
6,974
7,374
Total Liabilities
9,887
10,669
12,488
11,766
11,983
Shareholders' Equity
7,922
9,449
11,010
12,819
13,796
Total Equity
10,976
12,979
15,700
21,441
22,829
Net Working Capital
468
912
1,992
4,645
3,709
In Percentage (%)
Sales Growth
82.0% (23.6%)
4.9% 32.9%
9.8%
Gross Proft Margin
34.9% 35.7% 39.5% 36.5%
30.1%
Operating Proft Margin
15.7% 36.1% 31.6% 30.0%
19.6%
Net Proft Margin
9.0% 22.7% 20.1% 21.0%
13.1%
Net Proft to Equity Holders Margin
6.7% 16.9% 14.8% 11.8%
7.6%
Return on Assets
1
8.9% 13.8% 10.6% 11.4%
7.8%
Return on Equity
2
10.0% 16.2% 12.7% 11.6%
7.6%
Current Ratio (times)
1.1
1.3
1.5
2.0
1.8
Net Debt to Equity Ratio (times)
3
0.35
0.40
0.30
0.03
0.07
Total Debt to Total Assets Ratio (times)
0.30
0.29
0.30
0.22
0.19
1
Proft from operations divided by total assets
2
Net proft to equity holders divided by shareholders’ equity
3
Net debt divided by total equity
16